— Know what they know.
Not Investment Advice
GRRMF (OTC) is a cross-listing of GXI.DE (XETRA). Showing primary listing data.

GXI.DE

Gerresheimer AG
1W: +19.7% 1M: +13.0% 3M: -13.8% YTD: -22.6% 1Y: -74.1% 3Y: -71.6% 5Y: -73.5%
€21.06 ($24.35)
+0.30 (+1.45%)
 
XETRA · Healthcare · Medical - Instruments & Supplies · €717.1M · Alpha Radar Sell · Power 45
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap€717.1M ($829.1M)
52W Range14.83-76.15
Volume240,664
Avg Volume375,517
Beta0.57
Dividend€0.04
Analyst Ratings
No analyst coverage
Company Info
CEOUwe Ferdinand Röehrhoff
Employees13,632
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2007-06-11
Klaus-Bungert-Strasse 4
Düsseldorf 40468
DE
49 211 61 81 00
About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms